<DOC>
	<DOC>NCT01529203</DOC>
	<brief_summary>The aim of this study is to assess subjects' satisfaction linked to the pan facial management of rejuvenation with injections of Azzalure速 and Restylane速 fillers. This will be an open, multi-centre study.</brief_summary>
	<brief_title>Subjects' Satisfaction on Pan Facial Aesthetic Enhancement After Treatment With Azzalure速 and the Restylane速 Range</brief_title>
	<detailed_description />
	<mesh_term>Botulinum Toxins, Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>Main Male or female subjects, aged 18 to 64 years, seeking treatment for correction of dynamic wrinkles of the upper third of the face and correction of facial volume loss, and meeting other specific eligibility criteria Main Female subject who is pregnant, nursing or planning a pregnancy during the study Subject with any contraindications to the injection of hyaluronic acid (see package inserts) Subject with any contraindications to the injection of botulinum toxin (see package insert) Subject with a personal history of allergic/anaphylactic reactions including hypersensitivity to crossedlinked hyaluronic acid or botulinum toxin Concurrent treatment that, in the investigator's opinion, would interfere with the evaluation of the safety or efficacy of at least one of the study treatments Subject with a history of dissatisfaction with facial aesthetic procedures involving dermal implant injections or subject with unattainable expectations Subject currently enrolled in another investigational study or who participated in such a study in the past 30 days prior to baseline visit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>